Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.
Journal: Journal of hepatology
Published: April 07, 2023
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.
Journal: Antiviral therapy
Published: October 30, 2012
Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation.
Journal: Journal of clinical gastroenterology
Published: June 29, 2012
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response.
Journal: Journal of viral hepatitis
Published: January 14, 2012
Showing 1-4 of 4
Last Updated: 09/26/2026